- Home
- FITBO vs MRK Comparison
FITBO vs MRK Comparison
Compare FITBO & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
FITBO
Fifth Third Bancorp Depositary Shares each representing a 1/1000th ownership interest in a share of Non-Cumulative Perpetual Preferred Stock Series K
Current Price
Company Overview
Basic Information| Metric | FITBO | MRK |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | United States |
| Employees | 18616 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 268.7B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | FITBO | MRK |
|---|---|---|
| Price | $19.50 | $114.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $124.29 |
| AVG Volume (30 Days) | 16.7K | ★ 7.3M |
| Earning Date | N/A | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.97% |
| EPS Growth | N/A | ★ 8.01 |
| EPS | N/A | ★ 7.28 |
| Revenue | N/A | ★ $65,011,000,000.00 |
| Revenue This Year | N/A | $3.74 |
| Revenue Next Year | N/A | $5.47 |
| P/E Ratio | ★ N/A | $15.72 |
| Revenue Growth | N/A | ★ 1.31 |
| 52 Week Low | $19.19 | $75.40 |
| 52 Week High | $22.80 | $125.14 |
Technical Indicators
Market Signals| Indicator | FITBO | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 40.62 | 43.12 |
| Support Level | $19.20 | $113.82 |
| Resistance Level | $19.85 | $125.14 |
| Average True Range (ATR) | 0.15 | 2.50 |
| MACD | -0.01 | -0.81 |
| Stochastic Oscillator | 24.98 | 13.38 |
Price Performance
Historical ComparisonAbout FITBO Fifth Third Bancorp Depositary Shares each representing a 1/1000th ownership interest in a share of Non-Cumulative Perpetual Preferred Stock Series K
Fifth Third Bancorp is a midsize regional bank in the US, with total assets of over $210 billion as of December 2025. The bank is set to close its acquisition of Comercia on Feb. 1, 2026. Headquartered in Cincinnati, Ohio, Fifth Third has a strong presence in the US Midwest and is currently expanding in the US Southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and Treasury management, wealth and asset management, and capital markets.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).